In 2016, results from the LEADER trial of liraglutide in sufferers with form 2 diabetes helped jumpstart awareness of the aptitude characteristic of this new…
In 2016, results from the LEADER trial of liraglutide in sufferers with form 2 diabetes helped jumpstart awareness of the aptitude characteristic of this new…